NasdaqGM - Nasdaq Real Time Price USD

PROCEPT BioRobotics Corporation (PRCT)

56.42
+1.65
+(3.00%)
As of 3:00:07 PM EDT. Market Open.
Advanced Chart
Loading Chart for PRCT
  • Previous Close 54.77
  • Open 54.33
  • Bid 56.27 x 200
  • Ask 56.53 x 200
  • Day's Range 53.78 - 56.45
  • 52 Week Range 47.04 - 103.81
  • Volume 579,152
  • Avg. Volume 1,063,904
  • Market Cap (intraday) 3.121B
  • Beta (5Y Monthly) 1.10
  • PE Ratio (TTM) --
  • EPS (TTM) -1.69
  • Earnings Date Jul 30, 2025 - Aug 4, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 76.88

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

www.procept-biorobotics.com

756

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

More about PROCEPT BioRobotics Corporation

Recent News: PRCT

View More
View More

Performance Overview: PRCT

Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PRCT
29.94%
S&P 500 (^GSPC)
0.52%

1-Year Return

PRCT
18.46%
S&P 500 (^GSPC)
11.38%

3-Year Return

PRCT
58.29%
S&P 500 (^GSPC)
46.92%

5-Year Return

PRCT
61.19%
S&P 500 (^GSPC)
106.45%

Compare To: PRCT

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

PRCT
PROCEPT BioRobotics Corporation
56.42
+3.00%
Mkt Cap 3.121B
Industry Medical Devices
RXST
RxSight, Inc.
13.37
+0.98%
Mkt Cap 543.317M
Industry Medical Devices
CLPT
ClearPoint Neuro, Inc.
12.48
+0.40%
Mkt Cap 349.185M
Industry Medical Devices
LIVN
LivaNova PLC
43.76
+0.48%
Mkt Cap 2.386B
Industry Medical Devices
IRTC
iRhythm Technologies, Inc.
142.11
+1.17%
Mkt Cap 4.537B
Industry Medical Devices
INSP
Inspire Medical Systems, Inc.
152.65
-2.03%
Mkt Cap 4.502B
Industry Medical Devices
GMED
Globus Medical, Inc.
58.07
-0.17%
Mkt Cap 7.861B
Industry Medical Devices
RBOT
Vicarious Surgical Inc.
7.30
-5.07%
Mkt Cap 43.305M
Industry Medical Devices
KIDS
OrthoPediatrics Corp.
22.88
+0.11%
Mkt Cap 566.591M
Industry Medical Devices
OM
Outset Medical, Inc.
18.39
-0.59%
Mkt Cap 325.913M
Industry Medical Devices
ATEC
Alphatec Holdings, Inc.
12.84
+0.75%
Mkt Cap 1.876B
Industry Medical Devices

Statistics: PRCT

View More

Valuation Measures

Annual
As of 5/14/2025

  • Market Cap

    3.03B

  • Enterprise Value

    2.80B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    11.67

  • Price/Book (mrq)

    7.79

  • Enterprise Value/Revenue

    11.22

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -36.20%

  • Return on Assets (ttm)

    -13.36%

  • Return on Equity (ttm)

    -27.62%

  • Revenue (ttm)

    249.12M

  • Net Income Avi to Common (ttm)

    -90.19M

  • Diluted EPS (ttm)

    -1.69

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    316.21M

  • Total Debt/Equity (mrq)

    21.02%

  • Levered Free Cash Flow (ttm)

    -58.77M

View More

Research Analysis: PRCT

View More
View More

Company Insights: PRCT

Research Reports: PRCT

View More
View More

People Also Watch

RXST RxSight, Inc.
13.37
+0.98%
 
NUVL Nuvalent, Inc.
69.73
-1.82%
 
JANX Janux Therapeutics, Inc.
23.40
+3.45%
 
TMDX TransMedics Group, Inc.
121.90
-0.38%
 
EWTX Edgewise Therapeutics, Inc.
14.36
-1.31%
 
ACLX Arcellx, Inc.
57.80
-2.07%
 
PCVX Vaxcyte, Inc.
30.78
+4.62%
 
CWAN Clearwater Analytics Holdings, Inc.
23.93
-0.62%
 
CTKB Cytek Biosciences, Inc.
2.6800
-1.83%
 
TYRA Tyra Biosciences, Inc.
9.78
+1.14%
 
INTA Intapp, Inc.
56.64
-0.21%
 
RNA Avidity Biosciences, Inc.
28.64
+0.83%
 
TMCI Treace Medical Concepts, Inc.
6.72
-0.07%
 
CRNX Crinetics Pharmaceuticals, Inc.
30.96
-1.04%
 
VERA Vera Therapeutics, Inc.
21.22
+0.14%
 
PRVA Privia Health Group, Inc.
24.60
+1.23%